Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

50%

5 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3

5(62.5%)

N/A

2(25.0%)

Phase 1

1(12.5%)

8Total

Phase 3(5)

N/A(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06806956Enrolling By Invitation

Severe Malaria in Remote Areas- Closing the Evidence Gap

Role: lead

NCT06438562Not ApplicableCompleted

Evaluation of Vitamin A Absorption From Fortified Bouillon

Role: collaborator

NCT04109352Unknown

Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy

Role: collaborator

NCT02941159Phase 1Unknown

SF2000SD Clinical Trial in Zambia

Role: lead

NCT00852423Phase 3Completed

Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria

Role: collaborator

NCT00711906Phase 3Terminated

Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy

Role: collaborator

NCT01922713Not ApplicableCompleted

Effect of Daily Consumption of Orange Maize on Breast Milk Retinol in Lactating Zambian Women

Role: collaborator

NCT01695148Phase 3Completed

Efficacy of β-carotene Biofortified Maize in Reducing Vitamin A Deficiency Among Children

Role: collaborator

NCT00393679Phase 3Completed

Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children

Role: collaborator

NCT01053325Phase 3Completed

Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy

Role: collaborator

All 10 trials loaded